Colgate-Palmolive
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Colgate-Palmolive scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Colgate-Palmolive increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Colgate-Palmolive forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Colgate-Palmolive is part of the Global Alliance for Responsible Media and is a corporate partner of the National LGBT Chamber of Commerce (NGLCC). The company provides unconscious bias training for its employees and signed onto a 2015 amicus brief supporting Obergefell v. Hodges, legalizing same-sex marriage. For these reasons, Colgate-Palmolive receives a High Risk rating.
Board Bias
Expand Summary
CEO of Colgate-Palmolive
Noel Wallace
Summary:
Headquartered in New York, New York, Colgate-Palmolive is a member of the Fortune 250 operating in the Household and Personal Products industry. Noel Wallace and Noel Wallace serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $5,400 to Republican causes and $5,000 to Democratic causes. Under their tenure, Colgate-Palmolive currently holds a 'High Risk' risk rating.
Political Contributions of Leadership:
$5,400
$5,000
Republican
Democrat
Shareholder Proposals
Expand Summary
Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
---|---|---|---|---|---|
5/10/24 | Governance | Kenneth Steiner | Independent Board Chairman | Against | N/A |
5/12/23 | Governance | John Chevedden | Require Two Seperate People Hold the Offices of Chairman and CEO | Against | 34.40% |
5/12/23 | Governance | Kenneth Steiner | Require Excecutives to Retain Significant Stock | Against | 29.90% |
5/6/22 | Governance | Kenneth Steiner | Shareholder Ratification of Termination Pay Exceeding 2.99x Base & Bonus | Against | 43.28% |
5/6/22 | Social | National Legal and Policy Center | Report on Charitable Contributions | Against | 4.69% |
In the News
Expand Summary
AbbVie , Amgen , Bank of America (Merrill Lynch) , Caterpillar , Citigroup , Citizens Financial , Coca-Cola (Coke) , Colgate-Palmolive , CVS Health , Delta Air Lines , General Motors (GM) , JPMorgan Chase , Morgan Stanley (E-Trade) , Prudential Financial , Robert Half , Sherwin Williams , Uber , United Parcel Service (UPS) , Wells Fargo